Posted 3rd February 2020 by Liv Sewell
Automation and digitisation are becoming increasingly important in the modern environment of bioprocesses 4.0. A new wave of biopharmaceutical manufacturing is already breaking. Driven by the PAT initiative and the goal of a well-understood and optimally controlled process, the digital transformation of bioprocesses is inevitable.
Posted 18th November 2019 by Liv Sewell
Digital pathology is transforming possibilities for patient care and the nature of pathologists’ work. But it is clear that in low-income countries, access to pathology and laboratory medicine (PALM) services is very restricted and under-developed. Low-income countries bear a disproportionate share of the global disease burden, yet they are so under-resourced in the pathology and laboratory services that are vital for the accurate diagnosis and treatment of disease. This presents a huge issue for global health.
Given this global context, Rebecca Calder, Daniel Stevens and Zev Leifer’s poster, presented at the 5th Digital Pathology and AI Congress, is of notable significance.
Posted 21st October 2019 by Liv Sewell
Ahead of the 6th Digital Pathology and AI Congress: Europe in December, we are revisiting Professor Inti Zlobec’s research, presented at last year’s Congress, which is opening a whole field of digital pathology research. Zlobec’s research applies the latest digital pathology technology to produce high-quality tissue microarrays for biomarker analysis.
Posted 1st November 2017 by Jane Williams
Whether in a research or clinical lab, digital pathology holds a great deal of promise for all stakeholders. Earlier this year, a digital pathology platform obtained FDA clearance for whole slide imaging, thereby increasing both awareness and applicability of digital pathology. It may, however, be difficult for hospitals and laboratories to justify the acquisition costs of digital pathology platforms if one only looks on the surface. Matt Houliston from Definiens looks at the workflow and economic benefits of adopting digital pathology beyond the perhaps more obvious clinical benefits.